- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-6-6-6-mer
- Ligands
- 24 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 66 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.25: 2 residues within 4Å:- Chain A: Y.18, N.51
Ligand excluded by PLIPNAG.26: 4 residues within 4Å:- Chain A: N.112, T.114, V.117, F.147
Ligand excluded by PLIPNAG.27: 4 residues within 4Å:- Chain A: E.122, N.155, T.157
- Chain C: R.345
Ligand excluded by PLIPNAG.28: 1 residues within 4Å:- Chain A: N.224
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain A: E.271, N.272
- Chain C: K.548
Ligand excluded by PLIPNAG.30: 5 residues within 4Å:- Chain A: N.321, I.322, P.569, Q.570, T.571
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain A: E.330, F.332, N.333
Ligand excluded by PLIPNAG.32: 1 residues within 4Å:- Chain A: N.606
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain A: N.647
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain A: N.699
Ligand excluded by PLIPNAG.35: 4 residues within 4Å:- Chain A: A.696, E.1062, N.1064
- Chain B: Q.885
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain B: N.51
Ligand excluded by PLIPNAG.37: 5 residues within 4Å:- Chain B: V.110, N.112, T.114, V.117, F.147
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain B: E.122, N.155
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain B: N.224
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain B: E.271, N.272
Ligand excluded by PLIPNAG.41: 5 residues within 4Å:- Chain B: N.321, I.322, P.569, Q.570, L.572
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain B: E.330, F.332, N.333
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain B: N.606
Ligand excluded by PLIPNAG.44: 1 residues within 4Å:- Chain B: N.647
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain B: N.699
Ligand excluded by PLIPNAG.46: 4 residues within 4Å:- Chain B: A.696, E.1062, N.1064
- Chain C: Q.885
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain C: N.51
Ligand excluded by PLIPNAG.48: 5 residues within 4Å:- Chain C: V.110, N.112, T.114, V.117, F.147
Ligand excluded by PLIPNAG.49: 6 residues within 4Å:- Chain B: R.345, R.347, R.456
- Chain C: Q.105, N.155, T.157
Ligand excluded by PLIPNAG.50: 1 residues within 4Å:- Chain C: N.224
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Chain C: N.272
Ligand excluded by PLIPNAG.52: 2 residues within 4Å:- Chain C: N.321, Q.570
Ligand excluded by PLIPNAG.53: 1 residues within 4Å:- Chain C: N.333
Ligand excluded by PLIPNAG.54: 1 residues within 4Å:- Chain C: N.606
Ligand excluded by PLIPNAG.55: 2 residues within 4Å:- Chain C: H.645, N.647
Ligand excluded by PLIPNAG.56: 1 residues within 4Å:- Chain C: N.699
Ligand excluded by PLIPNAG.57: 1 residues within 4Å:- Chain C: N.1064
Ligand excluded by PLIPNAG.58: 2 residues within 4Å:- Chain J: Y.18, N.51
Ligand excluded by PLIPNAG.59: 4 residues within 4Å:- Chain J: N.112, T.114, V.117, F.147
Ligand excluded by PLIPNAG.60: 3 residues within 4Å:- Chain J: E.122, N.155, T.157
Ligand excluded by PLIPNAG.61: 1 residues within 4Å:- Chain J: N.224
Ligand excluded by PLIPNAG.62: 3 residues within 4Å:- Chain J: E.271, N.272
- Chain L: K.548
Ligand excluded by PLIPNAG.63: 6 residues within 4Å:- Chain J: N.321, I.322, P.569, Q.570, T.571, L.572
Ligand excluded by PLIPNAG.64: 2 residues within 4Å:- Chain J: F.332, N.333
Ligand excluded by PLIPNAG.65: 1 residues within 4Å:- Chain J: N.606
Ligand excluded by PLIPNAG.66: 1 residues within 4Å:- Chain J: N.647
Ligand excluded by PLIPNAG.67: 1 residues within 4Å:- Chain J: N.699
Ligand excluded by PLIPNAG.68: 4 residues within 4Å:- Chain J: A.696, E.1062, N.1064
- Chain K: Q.885
Ligand excluded by PLIPNAG.69: 1 residues within 4Å:- Chain K: N.51
Ligand excluded by PLIPNAG.70: 5 residues within 4Å:- Chain K: V.110, N.112, T.114, V.117, F.147
Ligand excluded by PLIPNAG.71: 5 residues within 4Å:- Chain J: R.345, R.347
- Chain K: E.122, N.154, N.155
Ligand excluded by PLIPNAG.72: 1 residues within 4Å:- Chain K: N.224
Ligand excluded by PLIPNAG.73: 2 residues within 4Å:- Chain K: E.271, N.272
Ligand excluded by PLIPNAG.74: 5 residues within 4Å:- Chain K: N.321, I.322, P.569, Q.570, L.572
Ligand excluded by PLIPNAG.75: 2 residues within 4Å:- Chain K: N.333, F.364
Ligand excluded by PLIPNAG.76: 1 residues within 4Å:- Chain K: N.606
Ligand excluded by PLIPNAG.77: 1 residues within 4Å:- Chain K: N.647
Ligand excluded by PLIPNAG.78: 1 residues within 4Å:- Chain K: N.699
Ligand excluded by PLIPNAG.79: 3 residues within 4Å:- Chain K: A.696, E.1062, N.1064
Ligand excluded by PLIPNAG.80: 1 residues within 4Å:- Chain L: N.51
Ligand excluded by PLIPNAG.81: 5 residues within 4Å:- Chain L: V.110, N.112, T.114, V.117, F.147
Ligand excluded by PLIPNAG.82: 9 residues within 4Å:- Chain K: A.342, W.343, N.344, R.345, R.456
- Chain L: Q.105, N.154, N.155, T.157
Ligand excluded by PLIPNAG.83: 1 residues within 4Å:- Chain L: N.224
Ligand excluded by PLIPNAG.84: 3 residues within 4Å:- Chain K: K.548
- Chain L: E.271, N.272
Ligand excluded by PLIPNAG.85: 2 residues within 4Å:- Chain L: N.321, Q.570
Ligand excluded by PLIPNAG.86: 1 residues within 4Å:- Chain L: N.333
Ligand excluded by PLIPNAG.87: 1 residues within 4Å:- Chain L: N.606
Ligand excluded by PLIPNAG.88: 2 residues within 4Å:- Chain L: H.645, N.647
Ligand excluded by PLIPNAG.89: 1 residues within 4Å:- Chain L: N.699
Ligand excluded by PLIPNAG.90: 1 residues within 4Å:- Chain L: N.1064
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yan, Q. et al., Antibodies utilizing VL6-57 light chains target a convergent cryptic epitope on SARS-CoV-2 spike protein and potentially drive the genesis of Omicron variants. Nat Commun (2024)
- Release Date
- 2024-08-21
- Peptides
- Spike glycoprotein,Fibritin,Expression Tag: ABCJKL
Light chain of H18 Fab: DFHMOQ
Heavy chain of H18 Fab: EGINPR - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CJ
GK
HL
ID
DF
FH
KM
LO
OQ
QE
EG
JI
MN
NP
PR
R
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-6-6-6-mer
- Ligands
- 24 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 66 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yan, Q. et al., Antibodies utilizing VL6-57 light chains target a convergent cryptic epitope on SARS-CoV-2 spike protein and potentially drive the genesis of Omicron variants. Nat Commun (2024)
- Release Date
- 2024-08-21
- Peptides
- Spike glycoprotein,Fibritin,Expression Tag: ABCJKL
Light chain of H18 Fab: DFHMOQ
Heavy chain of H18 Fab: EGINPR - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CJ
GK
HL
ID
DF
FH
KM
LO
OQ
QE
EG
JI
MN
NP
PR
R